Burden of post-traumatic stress disorder in postgenocide Rwandan population following exposure to 1994 genocide against the Tutsi: A meta-analysis.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 02 12 2019
revised: 21 05 2020
accepted: 17 06 2020
pubmed: 14 7 2020
medline: 16 2 2021
entrez: 14 7 2020
Statut: ppublish

Résumé

The 1994 genocide against Tutsi resulted in a massive death toll that reached one million people. Despite the tremendous efforts made to mitigate the adverse effects of the genocide, a substantial burden of mental health disorders still exists including the notably high prevalence of post-traumatic stress disorder (PTSD) among genocide survivors. However, a synthesized model of PTSD vulnerability in this population is currently lacking. A meta-analysis of 19 original research studies that reported PTSD prevalence (n = 12,610). Medline-PubMed and Science.gov were key search engines. Random-Effects Model (k = 19; tau^2 estimator: DL) was applied. Data extraction, synthesis, and meta-analysis were carried out using R. The total of 2957 out of 11,746 individuals suffered from PTSD. The summary proportion is 25% (95% CI=0.16,0.36). The tau^2 is 0.06 (95% CI=0.03,0.14) in the absence of subgroups, and the Q-statistic is 2827.65 (p<0.0001), all of which suggests high heterogeneity in the effect sizes. Year of data collection and Year of publication were significant moderators. PTSD pooled prevalence in the genocide survivor category was estimated at 37% (95% CI=0.21,0.56). The PTSD prevalence among genocide survivors is considerably higher compared to the general Rwandan population. The burden of PTSD in the general Rwandan population declined significantly over time, likely due to treatment of symptoms through strong national mental health programs, peace building and resolution of symptoms over time. To the best of our knowledge little evidence has reported the burden of PTSD prevalence in African post conflict zones particularly in Rwanda. Limitations of our review include the use of retrospective studies and studies with very small sample sizes, as well as language criterion.

Sections du résumé

BACKGROUND
The 1994 genocide against Tutsi resulted in a massive death toll that reached one million people. Despite the tremendous efforts made to mitigate the adverse effects of the genocide, a substantial burden of mental health disorders still exists including the notably high prevalence of post-traumatic stress disorder (PTSD) among genocide survivors. However, a synthesized model of PTSD vulnerability in this population is currently lacking.
METHODS
A meta-analysis of 19 original research studies that reported PTSD prevalence (n = 12,610). Medline-PubMed and Science.gov were key search engines. Random-Effects Model (k = 19; tau^2 estimator: DL) was applied. Data extraction, synthesis, and meta-analysis were carried out using R.
RESULTS
The total of 2957 out of 11,746 individuals suffered from PTSD. The summary proportion is 25% (95% CI=0.16,0.36). The tau^2 is 0.06 (95% CI=0.03,0.14) in the absence of subgroups, and the Q-statistic is 2827.65 (p<0.0001), all of which suggests high heterogeneity in the effect sizes. Year of data collection and Year of publication were significant moderators. PTSD pooled prevalence in the genocide survivor category was estimated at 37% (95% CI=0.21,0.56).
CONCLUSION
The PTSD prevalence among genocide survivors is considerably higher compared to the general Rwandan population. The burden of PTSD in the general Rwandan population declined significantly over time, likely due to treatment of symptoms through strong national mental health programs, peace building and resolution of symptoms over time. To the best of our knowledge little evidence has reported the burden of PTSD prevalence in African post conflict zones particularly in Rwanda.
LIMITATION
Limitations of our review include the use of retrospective studies and studies with very small sample sizes, as well as language criterion.

Identifiants

pubmed: 32658827
pii: S0165-0327(20)32375-2
doi: 10.1016/j.jad.2020.06.017
pmc: PMC7395874
mid: NIHMS1606572
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-13

Subventions

Organisme : NIMH NIH HHS
ID : U01 MH115485
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA254568
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that there is no competing interest.

Auteurs

Clarisse Musanabaganwa (C)

Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda; Medical Research Center, Rwanda Biomedical Center, Ministry of Health, Kigali, Rwanda; Genomics Program, College of Public Health, University of South Florida, Florida, USA.

Stefan Jansen (S)

Department of Clinical Psychology, College of Medicine and Health Sciences, University of Rwanda, Huye, Rwanda; Directorate of Research and Innovation, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Segun Fatumo (S)

London School of Hygiene and Tropical Medicine, Keppel St, Bloomsbury, London, UK; Uganda Medical Informatics Centre-MRC/UVRI, Entebbe, Uganda; Genomics Program, College of Public Health, University of South Florida, Florida, USA.

Eugene Rutembesa (E)

Department of Clinical Psychology, College of Medicine and Health Sciences, University of Rwanda, Huye, Rwanda.

Jean Mutabaruka (J)

Department of Clinical Psychology, College of Medicine and Health Sciences, University of Rwanda, Huye, Rwanda.

Darius Gishoma (D)

Department of Clinical Psychology, College of Medicine and Health Sciences, University of Rwanda, Huye, Rwanda.

Annette Uwineza (A)

Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Yvonne Kayiteshonga (Y)

Division of Mental Health, Rwanda Biomedical Center, Ministry of Health, Kigali, Rwanda.

Amal Alachkar (A)

Department of Pharmacology, School of Medicine, University of California Irvine, California, USA.

Derek Wildman (D)

Genomics Program, College of Public Health, University of South Florida, Florida, USA.

Monica Uddin (M)

Genomics Program, College of Public Health, University of South Florida, Florida, USA.

Leon Mutesa (L)

Centre for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda. Electronic address: lmutesa@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH